As of 2026-06-16, the Relative Valuation of Exagen Inc (XGN) is (12.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.67 USD, the upside of Exagen Inc based on Relative Valuation is -369.0%.
The range of the Relative Valuation is (12.04) - (13.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 19.1x | 16.4x |
| Forward P/E multiples | 12.4x - 16.1x | 13.7x |
| Fair Price | (12.04) - (13.42) | (12.56) |
| Upside | -357.7% - -387.4% | -369.0% |
| Date | P/E |
| 2026-06-12 | -5.59 |
| 2026-06-11 | -5.37 |
| 2026-06-10 | -5.02 |
| 2026-06-09 | -5.16 |
| 2026-06-08 | -5.03 |
| 2026-06-05 | -5.14 |
| 2026-06-04 | -5.74 |
| 2026-06-03 | -5.44 |
| 2026-06-02 | -5.77 |
| 2026-06-01 | -6.41 |
| 2026-05-29 | -5.97 |
| 2026-05-28 | -6.09 |
| 2026-05-27 | -6.00 |
| 2026-05-26 | -5.54 |
| 2026-05-22 | -5.10 |
| 2026-05-21 | -5.12 |
| 2026-05-20 | -4.59 |
| 2026-05-19 | -4.47 |
| 2026-05-18 | -4.18 |
| 2026-05-15 | -4.36 |
| 2026-05-14 | -4.61 |
| 2026-05-13 | -4.16 |
| 2026-05-12 | -4.44 |
| 2026-05-11 | -4.77 |
| 2026-05-08 | -3.53 |
| 2026-05-07 | -3.52 |
| 2026-05-06 | -3.70 |
| 2026-05-05 | -3.70 |
| 2026-05-04 | -3.71 |
| 2026-05-01 | -3.67 |
| 2026-04-30 | -3.47 |
| 2026-04-29 | -3.31 |
| 2026-04-28 | -3.27 |
| 2026-04-27 | -3.28 |
| 2026-04-24 | -3.23 |
| 2026-04-23 | -3.21 |
| 2026-04-22 | -3.44 |
| 2026-04-21 | -3.49 |
| 2026-04-20 | -3.58 |
| 2026-04-17 | -3.69 |
| 2026-04-16 | -3.65 |
| 2026-04-15 | -3.68 |
| 2026-04-14 | -3.64 |
| 2026-04-13 | -3.56 |
| 2026-04-10 | -3.63 |
| 2026-04-09 | -3.70 |
| 2026-04-08 | -3.69 |
| 2026-04-07 | -3.59 |
| 2026-04-06 | -3.69 |
| 2026-04-02 | -3.67 |